Title : Inhibiting sEH suppresses NF-B p65 signaling and reduces CXCL10 expression as a potential therapeutic target in HT - Feng_2024_J.Clin.Endocrinol.Metab__ |
Author(s) : Feng J , Xu X , Cai W , Yang X , Niu R , Han Z , Tian L |
Ref : J Clinical Endocrinology Metab , : , 2024 |
Abstract : Feng_2024_J.Clin.Endocrinol.Metab__ |
ESTHER : Feng_2024_J.Clin.Endocrinol.Metab__ |
PubMedSearch : Feng_2024_J.Clin.Endocrinol.Metab__ |
PubMedID: 38478377 |
Feng J, Xu X, Cai W, Yang X, Niu R, Han Z, Tian L (2024)
Inhibiting sEH suppresses NF-B p65 signaling and reduces CXCL10 expression as a potential therapeutic target in HT
J Clinical Endocrinology Metab
:
Feng J, Xu X, Cai W, Yang X, Niu R, Han Z, Tian L (2024)
J Clinical Endocrinology Metab
: